~~<i id='16E38AA1EC'><strike id='16E38AA1EC'><tt id='16E38AA1EC'><pre id='16E38AA1EC'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

fashion

author：fashion 2025-09-29 21:23:27 - browse：5694

Bruce Broussard. -- health business coverage from STAT — Humana CEO Bruce Broussard Jason DeCrow/AP

Bruce Broussard, CEO of health insurance giant Humana, will step down next year after leading the company for more than a decade.

Humana named Jim Rechtin — who is the CEO of Envision Healthcare, the controversial physician staffing firm that is working its way through bankruptcy — as Broussard’s replacement. Rechtin will serve as president and chief operating officer starting Jan. 8 and then take over as CEO in the “latter half of 2024,” the company said in a news release.

Humana’s stock fell by more than 2% on the news Wednesday morning.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Timeline: Key moments in fight for gay rights

hotspot

focus

Wikipedia

explore

knowledge

entertainment

IftherewasonemomentthatledKathleenBachynskitoacareerstudyingthepublichealthsignificanceofsportsinjur

WSS

Eli Lilly’s Mounjaro succeeds in second weight

Supreme Court to hear if Covid misinformation is protected speech

U.K. agency declines to back Eli Lilly’s Mounjaro for type 2 diabetes

Fertility clinic egg and embryo storage is a disaster

Biden administration plans revamp of organ transplant system

What a koala virus tells us about the human genome

focus

fashion

hotspot

Hollywood unions extend contract negotiations for actors

Cherokee Nation medical school graduates its first class

Medical records are filled with copy

Readout Newsletter: Raw milk, Wegovy tests, Eisai and Biogen

Bright Health sells Medicare Advantage business to Molina

As H5N1 spreads in cows, experts warn against drinking raw milk

Activists slam private health insurers over coverage restrictions

Biogen nominates mother of director’s child to replace him on board

United colonoscopy coverage change 'may cost lives,' doctors say

Hottest summer in 2,000 years puts focus on extreme heat, health

focus

Biogen nominates mother of director’s child to replace him on board

Cherokee Nation medical school graduates its first class

HHS suspends federal funding for EcoHealth Alliance

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

Novo pauses ads for weight loss drug Wegovy amid demand

U.K. agency declines to back Eli Lilly’s Mounjaro for type 2 diabetes

Wikipedia

explore

knowledge

entertainment